Moody’s Investors Service has upgraded the corporate credit rating of Fresenius from Ba1 to Baa3 with a stable outlook.

The upgrade reflects Moody's view that Fresenius' business profile has improved over the last years supported by higher business and geographical diversification and increased scale as well as a strong track record of profitable growth and deleveraging post acquisitions.

In January 2015, Standard & Poor’s upgraded the corporate credit rating of Fresenius from previously BB+ to BBB- with a stable outlook.

Fresenius continues to view itself as an active consolidator in its markets and will continue to focus on financing acquisitions primarily with debt.

 

 

Moody’s Investors Service has upgraded the corporate credit rating of Fresenius from Ba1 to Baa3 with a stable outlook.

The upgrade reflects Moody's view that Fresenius' business profile has improved over the last years supported by higher business and geographical diversification and increased scale as well as a strong track record of profitable growth and deleveraging post acquisitions.

In January 2015, Standard & Poor’s upgraded the corporate credit rating of Fresenius from previously BB+ to BBB- with a stable outlook.

Fresenius continues to view itself as an active consolidator in its markets and will continue to focus on financing acquisitions primarily with debt.

 

Fresenius Helios has presented the plan for its new main building at HELIOS Hospital Dr. Horst Schmidt in the German city of Wiesbaden. The seven-story structure, with total floor space of almost 100,000 square meters (more than 1 million square feet), will be built on an open site near the existing hospital building. Patients’ waiting times and the distances they need to cover will be significantly reduced in the new building, which will have 22 operating rooms and more than 900 beds. Construction is scheduled to start next spring, with completion in 2020. Building costs are estimated at around €200 million.

Fresenius Medical Care has opened its China Design Center, in Caohejing Hi-Tech Park in Shanghai. The new facility represents a ramping-up of research and development activities outside of Europe and the United States, and underscores Fresenius Medical Care’s commitment to making its world-leading dialysis treatments and technologies more widely available to patients in China and other emerging markets. In addition to developing a deeper insight into the needs of these markets, the company aims to provide even more innovative and cost-effective solutions for treating kidney disease.

HELIOS Hospital Dr. Horst Schmidt, in the German city of Wiesbaden, will begin training about 160 students annually in nursing and other patient care occupations. The internal continuing education program for all employees now includes more than 2,000 different courses. HELIOS has invested about €3 million in new facilities for the training center, which will include seven modern teaching rooms, practice rooms, and a library.